An outstanding feature of our point-of-care test is its high specifity in detection of patients with good health. We have achieved a 99.8% correlation with the PCR smear test in the detection of healthy individuals not suffering from SARS-CoV-2 who were neither acutely nor previously infected with the virus.
The test is restricted to healthcare and pharmaceutical professionals.
The daily use of the rapid test relieves the process organisation at doctors and hospitals. Due to the quick and easy risk identification or detection of the infection with SARS-CoV-2, a clear distinction between acutely or previously infected and non-infected patients is possible.
Negative compliance rate
99,8% conformance rate (specificity rate) for 272 negative controls with subjects not acutely or previously infected with SARS-CoV-2.
Positive compliance rate of the infection
Early stage, day area 4-10: IgM, 70%
In late stages, area day 11-24: IgM, 92,3 %.
In late stages, area day11-24: IgG 98,6%.